Axon Q2 revenue rises 33% to $669 million; raises 2025 revenue outlook
Axon reported second-quarter 2025 revenue of $669 million, up 33% year over year, and raised its full-year 2025 revenue outlook to $2.65 billion to $2.73 billion from $2.60 billion to $2.70 billion. Net income was $36 million, but the company posted a $1 million operating loss driven by $139 million of stock-based compensation expense, and total gross margin fell 40 basis points year over year to 60.4%. For shareholders, the higher revenue and raised guidance are the main headline measures, while stock-based compensation weighed on reported operating results.
Key points
- Q2 2025 revenue of $669 million rose 33% year over year; Software & Services revenue rose 39% to $292 million.
- Full-year 2025 revenue outlook raised to $2.65 billion to $2.73 billion, from $2.60 billion to $2.70 billion previously.
- Full-year 2025 Adjusted EBITDA outlook raised to $665 million to $685 million, from $650 million to $675 million previously.
- Q2 net income was $36 million, or $0.44 per diluted share; operating loss of $1 million included $139 million of stock-based compensation expense.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:10 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 04, 2025.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.